Join to View Full Profile
40 Temple Street, Suite 1ATemple Medical CenterNew Haven, CT 06510
Dr. Silveira is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Transplant Hepatology, 2009 - 2010- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 2006 - 2009
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2003 - 2006
Faculdade de Medicina da Universidade Federal do Rio de JaneiroClass of 2002
Certifications & Licensure
CT State Medical License 2016 - 2027
OH State Medical License 2011 - 2018
MN State Medical License 2005 - 2012
American Board of Internal Medicine Gastroenterology- American Board of Internal Medicine Transplant Hepatology
Clinical Trials
- Mindfulness - Based Intervention in the Treatment of Fatigue in Patients With Primary Biliary Cholangitis Start of enrollment: 2018 Nov 19
Publications & Presentations
PubMed
- Long-Term Use of Fenofibrate as Second-Line Therapy in Primary Biliary Cholangitis: A Retrospective Study.Mariko Maxwell, Yanhong Deng, Bonnie Chen, Marina G Silveira, James L Boyer
Alimentary Pharmacology & Therapeutics. 2026-05-01 - Seladelpar in patients with primary biliary cholangitis and compensated cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies.Stuart C Gordon, Alejandra Villamil, Ira M Jacobson, Eric J Lawitz, Ziad Younes
Hepatology Communications. 2026-05-01 - 23 citationsAdvancing diagnosis and management of liver disease in adults through exome sequencing.Melanie Zheng, Aaron Hakim, Chigoziri Konkwo, Aimee M Deaton, Lucas D Ward
Ebiomedicine. 2023-09-01
Grant Support
- GABA and NPY Signaling Interact to Shape Inhibition in the Auditory Tectothalamic PathwayUNIVERSITY OF TEXAS SAN ANTONIO2021–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
